Banco Santander, BBVA, and Deutsche Bank stress-test $17.5B in high-yield risk transfers

Three of Europe’s biggest banks are quietly stress-testing one of finance’s more intricate instruments. Banco Santander, BBVA, and Deutsche Bank are arranging significant risk transfer deals covering at least $17.5 billion in loans, according to a Bloomberg report published September 14, 2026.

What these deals actually are

A significant risk transfer, or SRT, works a bit like an insurance policy you sell to someone else. The bank keeps the loans on its books but carves off the riskiest slice of potential losses and sells that exposure to outside investors.

In exchange, those investors collect elevated yields, often above 10% on specific tranches. The bank, meanwhile, frees up regulatory capital without having to actually sell the underlying assets.

More precisely, what gets freed up is Common Equity Tier 1 capital, the core financial buffer regulators care most about. Releasing CET1 through an SRT costs less than issuing new equity.

The technical label for many of these structures is synthetic securitization, a term that carries some historical baggage from the 2008 financial crisis.

What the three banks are specifically targeting

Santander is reportedly evaluating five separate SRT transactions, with a focus on UK commercial real estate loans and Brazilian SME financing.

Deutsche Bank has prior form here. Earlier in 2026, both Deutsche and Santander participated in a synthetic securitization tied to a $500 million trade-finance portfolio backed by the World Bank and International Finance Corporation.

The European SRT market has grown substantially in recent years. Total synthetic securitizations across Europe reached approximately €320 billion by mid-2025.

Why regulators are watching closely

The ECB, IMF, and Bank for International Settlements have each raised concerns about SRTs, and their critiques share a common thread: opacity. When risk moves from a bank’s balance sheet to a dispersed group of investors, tracking where that risk ultimately sits becomes genuinely difficult.

For institutional investors considering participation, the calculus involves weighing those attractive double-digit yields against credit deterioration in the underlying loan pools and a regulatory environment that could affect how these instruments are classified and treated on investor balance sheets.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.